PRE-EMPTIVE OR PROPHYLACTIC THERAPY FOR REACTIVATION OF HEPATITIS B VIRUS IN PATIENTS WHO RECEIVED IMMUNOSUPPRESSIVE OR CYTOTOXIC THERAPY: EVALUATION OF BOTH HBsAg-POSITIVE AND HBsAg-NEGATIVE COHORTS

被引：0

作者：

Tamori, A. ^{[1
]}

Koike, T. ^{[1
]}

Goto, H. ^{[1
]}

Tada, M. ^{[1
]}

Morikawa, H. ^{[1
]}

Enomoto, M. ^{[1
]}

Nakatani, T. ^{[1
]}

Hino, M. ^{[1
]}

Kawada, N. ^{[1
]}

机构：

[1] Osaka City Univ, Grad Sch Med, Osaka 558, Japan

来源：

JOURNAL OF HEPATOLOGY | 2013年 / 58卷

关键词：

D O I：

10.1016/S0168-8278(13)60433-X

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

431

引用

页码：S176 / S176

页数：1

共 50 条

[41] HBsAg-negative/anti-HBc-positive patients treated with rituximab: prophylaxis or monitoring to prevent hepatitis B reactivation?
Linda Drößler
Clara Lehmann
Karin Töpelt
Dirk Nierhoff
Jörg J. Vehreschild
Jan Rybniker
Michael Hallek
Julia Fischer
Verena Stormberg
Gerd Fätkenheuer
Ulrike Wieland
Norma Jung
Infection, 2019, 47 : 293 - 300
[42] Hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients receiving rituximab for lymphoma: a meta-analysis
Mozessohn, L.
Chan, K. K. W.
Feld, J. J.
Hicks, L. K.
JOURNAL OF VIRAL HEPATITIS, 2015, 22 (10) : 842 - 849
[43] HBsAg-negative/anti-HBc-positive patients treated with rituximab: prophylaxis or monitoring to prevent hepatitis B reactivation?
Droessler, Linda
Lehmann, Clara
Toepelt, Karin
Nierhoff, Dirk
Vehreschild, Joerg J.
Rybniker, Jan
Hallek, Michael
Fischer, Julia
Stormberg, Verena
Faetkenheuer, Gerd
Wieland, Ulrike
Jung, Norma
INFECTION, 2019, 47 (02) : 293 - 300
[44] Incidence and Risk Factors of Hepatitis B Virus Reactivation in HBsAg-Negative, Anti-Hbc-Positive Kidney Transplant Recipients
Lee, Hyo Young
Cho, Eun Ju
Chung, Sung Won
Kim, Minseok Albert
Kim, Sun Woong
Yoon, Jun Sik
Chang, Young
Lee, Yun Bin
Lee, Jeong-Hoon
Yu, Su Jong
Kim, Yoon Jun
Yoon, Jung-Hwan, Sr.
HEPATOLOGY, 2018, 68 : 1216A - 1216A
[45] Allogeneic Hematopoietic Stem Cell Transplantation From HBsAg-Positive Donors Into HBsAg-Negative Recipients: A Safety and Practicable Regimen Under Active Prophylactic Anti-HBV Therapy
Hu, Yongxian
Luo, Yi
Tan, Yamin
Lai, Xiaoyu
Shi, Jimin
He, Jingsong
Zheng, Gaofeng
Zheng, Weiyan
Xie, Wanzhuo
Cai, Zhen
Huang, He
BLOOD, 2011, 118 (21) : 850 - 851
[46] Viral Factors of Patients with Fulminant Hepatic Failure Due to Hepatitis B Virus Reactivation from HBsAg-negative Status
Umemura, Takeji
Ota, Masao
Katsuyama, Yoshihiko
Joshita, Satoru
Kiyosawa, Kendo
Tanaka, Eiji
HEPATOLOGY, 2012, 56 : 634A - 635A
[47] REACTIVATION OF HEPATITIS-B VIRUS-INFECTION INDUCED BY INTERFERON (IFN) IN HBSAG-POSITIVE, ANTIHCV-POSITIVE PATIENTS
VILLA, E
GROTTOLA, A
TRANDE, P
SEIUM, Y
REBECCHI, AM
DUGANI, A
MANENTI, F
LANCET, 1993, 341 (8857): : 1413 - 1413
[48] DIAGNOSTIC SIGNIFICANCE OF INTRAHEPATOCELLULAR HEPATITIS-B-SURFACE-ANTIGEN (HBSAG), HEPATITIS-B-CORE-ANTIGEN (HBCAG) AND IGG FOR CLASSIFICATION OF INFLAMMATORY LIVER-DISEASES - (STUDIES ON HBSAG-POSITIVE AND HBSAG-NEGATIVE PATIENTS)
ARNOLD, W
MEYERZUMBUSCHENFELDE, KH
HESS, G
KNOLLE, J
KLINISCHE WOCHENSCHRIFT, 1975, 53 (22): : 1069 - 1074
[49] Increased Detection of HBV DNA in HBsAg-Positive and HBsAg-Negative South African HIV/AIDS Patients Enrolling for Highly Active Antiretroviral Therapy at a Tertiary Hospital
Lukhwareni, Azwidowi
Burnett, Rosemary J.
Selabe, S. Gloria
Mzileni, M. Olga
Mphahlele, M. Jeffrey
JOURNAL OF MEDICAL VIROLOGY, 2009, 81 (03) : 406 - 412
[50] REACTIVATION OF HEPATITIS B VIRUS ESCAPE MUTANTS IN A HBSAG NEGATIVE, ANTI-HBS POSITIVE PATIENT AFTER RITUXIMAB THERAPY
Rehman, Fnu Khalil Ur
Rahman, Mansoor
Usama, Fatima
Rasikh, Rohullah
Hassam, Khawaja
Danishwar, Mahmood
Ullah, Mati Dad Ullah
Lau, Daryl
GASTROENTEROLOGY, 2024, 166 (05) : S1612 - S1612

← 1 2 3 4 5 →